Overview

Stimulant Versus Nonstimulant Medication for Attention Deficit Hyperactivity Disorder in Children

Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
This study will determine the effectiveness of stimulant and nonstimulant medication in treating the symptoms of attention deficit hyperactivity disorder (ADHD) in children and adolescents.
Phase:
Phase 4
Details
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
National Institute of Mental Health (NIMH)
Collaborator:
National Institute of Mental Health (NIMH)
Treatments:
Atomoxetine Hydrochloride
Methylphenidate